CVR 24231712Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)BirkerødFounded 1 Jul 1999
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about BactiQuant A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
19
CVR, Aug 2026
-3 (-13.6%) over 12 months
Revenue
8.3M
DKK, annual report 2025
+15.9% on 2024
Result
-13.8M
DKK, annual report 2025
Equity
17.3M
DKK, annual report 2025
MVA & CO HOLDING ApSCVR 31468841, 25% to under 33.3% of capital and votes
Murugasan Claes Nielsen5% to under 10% of capital and votes
Operating company
Dandex estimate: 19 employees registered in 2026Henrik Brian Sønderup Sørensensince 1 Mar 2021
Morten Millersince 1 Jul 1999
Murugasan Claes Nielsensince 1 Dec 2025
Owners of 5% or more. CVR registers shares in bands, not exact figures.
5% to under 10% of capital and votessince 18 Nov 2025
CVR 3146884125% to under 33.3% of capital and votesnotified 27 Sep 2023since 20 May 2008
CVR 314688335% to under 10% of capital and votesnotified 13 May 202620 May 2008 to 28 Apr 2026
CVR 337475785% to under 10% of capital and votesnotified 10 Jun 202417 Dec 2020 to 10 Jun 2024
BactiQuant A/S holds no Danish company now.
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR.
CVR 3377354450% to under 66.7% of capital and votes9 Sep 2016 to 13 Aug 2020
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Founded 1 Jul 1999.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 19 employees, 8 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Q4 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | No count | 1 | 2 | 3 | 4 | 2 | 2 | 2 | 2 | 3 | 2 | No count | No count | No count | No count | 4 | 5 | 14 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 14 | 15 | 15 | 16 | 15 | 14 | 15 | 19 | 19 | 19 | 18 | 17 | 18 | 17 | 19 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 15 | 17 | 15 | 16 | 17 | 21 | 20 | 21 | 22 | 23 | 23 | 23 | 23 | 22 | 24 | 21 | 20 | 17 | 18 | 19 | 21 | 21 | 22 | 21 | 21 | 21 | 22 | 23 | 22 | 21 | 22 | 22 | 22 | 22 | 21 | 20 | 21 | 21 | 22 | 21 | 20 | 22 | 20 | 6 | 7 | 9 | 9 | 16 | 16 | 21 | 22 | 24 | 28 | 28 | 28 | 26 | 27 | 28 | 28 | 28 | 28 | 26 | 24 | 24 | 24 | 22 | 22 | 22 | 22 | 23 | 23 | 24 | 24 | 22 | 23 | 24 | 22 | 21 | 21 | 19 | 21 | 21 | 21 | 20 | 20 | 19 | 19 | 20 | 20 | 21 | 19 | 19 | 18 | 22 | 23 | 23 | 24 | 23 | 22 | 24 | 23 | 23 | 25 | 24 | 25 | 23 | 22 | 22 | 22 | 21 | 19 |
| FTE | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 3 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 6 | 6 | 5 | 6 | 7 | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 8 | 7 | 7 | 8 | 8 | 8 | 9 | 8 | 9 | 8 | 8 | 8 | 8 | 9 | 8 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 8 | 7 | 7 | 8 | 7 | 9 | 8 | 9 | 9 | 8 | 9 | 9 | 10 | 9 | 10 | 11 | 10 | 10 | 10 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 5 | 6 | 6 | 8 | 13 | 12 | 13 | 13 | 15 | 14 | 16 | 17 | 14 | 14 | 15 | 17 | 16 | 16 | 16 | 14 | 14 | 14 | 13 | 13 | 12 | 12 | 12 | 13 | 12 | 13 | 13 | 13 | 14 | 14 | 14 | 16 | 11 | 12 | 13 | 12 | 12 | 12 | 11 | 11 | 12 | 11 | 12 | 14 | 11 | 12 | 12 | 14 | 14 | 14 | 13 | 13 | 13 | 13 | 14 | 17 | 13 | 15 | 12 | 11 | 12 | 9 | 9 | 8 |
| Series | Quarterly | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Revenue 8.3M, Gross profit not reported, Operating profit -12.5M, Result for the year -13.8M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 28.1M, Equity 17.3M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8,359 | 12,389 | 12,303 | 7,175 | 8,319 |
| Gross profit | -2,955 | -1,152 | -756 | -3,357 | Not reported |
| Operating profit | -12,679 | -13,677 | -10,903 | -12,643 | -12,498 |
| Result for the year | -13,552 | -14,185 | -13,104 | -13,723 | -13,833 |
| Equity | 21,063 | 14,307 | 14,412 | 689 | 17,261 |
| Total assets | 24,518 | 23,179 | 25,503 | 14,695 | 28,068 |
| Employees (average) | 11 | 14 | 12 | 11 | 12 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | 52.5% | 48.2% | -0.7% | -41.7% | 15.9% |
| EBIT margin (overskudsgrad) | -151.7% | -110.4% | -88.6% | -176.2% | -150.2% |
| EBITDA | -11,807 | -12,340 | -9,494 | -11,005 | -10,922 |
| EBITDA margin (EBITDA-margin) | -141.2% | -99.6% | -77.2% | -153.4% | -131.3% |
| Employee growth (vækst i antal ansatte) | 57.1% | 27.3% | -14.3% | -8.3% | 9.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 2,194 | 757 | 541 | 335 | 0 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
How each credit metric is calculated:
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for BactiQuant A/S:
Have Pro? Sign in.
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 9,222,997, cash price 44.60, implied value 92,896,736 | 44.60 | 9,222,997 | 92,896,736 | 2,082,886 | |
| IncreaseCashPaid in 16,300,000, cash price 40.00, implied value 75,043,712 | 40.00 | 16,300,000 | 75,043,712 | 1,876,093 | |
| IncreaseCashPaid in 14,685,928, cash price 50.00, implied value 73,429,640 | 50.00 | 14,685,928 | 73,429,640 | 1,468,593 | |
| IncreaseCashPaid in 13,706,865, cash price 70.00, implied value 82,241,198 | 70.00 | 13,706,865 | 82,241,198 | 1,174,874 | |
| IncreaseCashPaid in 4,000,002, cash price 139.20, implied value 136,285,416 | 139.20 | 4,000,002 | 136,285,416 | 979,062 | |
| IncreaseCashPaid in 4,000,006, cash price 143.20, implied value 136,086,719 | 143.20 | 4,000,006 | 136,086,719 | 950,326 | |
| IncreaseCashPaid in 27,000,001, cash price 111.00, implied value 102,385,651 | 111.00 | 27,000,001 | 102,385,651 | 922,393 | |
| IncreaseCashPaid in 649,800, cash price 12.00, implied value 8,149,800 | 12.00 | 649,800 | 8,149,800 | 679,150 |
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseNot read from the announcement | None | None | None | 625,000 | |
| DecreaseMoved to a reserve | None | None | None | 542,570 | |
| IncreaseContribution in kindPaid in 2,270,399 | None | 2,270,399 | None | 567,570 | |
| IncreaseBonus issue from reserves | None | None | None | 525,000 | |
| IncreaseNot read from the announcement | None | None | None | 500,000 | |
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital. 2 steps could not be read that way and stand as registered.
Demerger (spaltning), as the demerged company (indskydende selskab)
Merger (fusion), as the continuing company (fortsættende selskab)
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
The newest 50 of 54 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Vedtægter ændret: 21.10.2026
Kapitalforhøjelsen er besluttet den 21.10.2026.
kr. 206.793,65, indbetalt kontant, kurs 4.460,00.
Kapitalen udgør herefter kr. 2.082.886,45.
Direktion:
Fratrådte:
Jesper Møgelvang, den 23.09.2026.
Vedtægter ændret: 23.09.2026
Bestyrelse:
Fratrådte:
Mette Juhl Jørgensen, den 28.04.2026.
Vedtægter ændret: 28.04.2026
Vedtægter ændret: 01.12.2025
Vedtægter ændret: 18.11.2025
Kapitalforhøjelsen er besluttet den 18.11.2025.
kr. 407.500,00, indbetalt kontant, kurs 4.000,00.
Kapitalen udgør herefter kr. 1.876.092,80.
Vedtægter ændret: 23.04.2025
Revision:
Fratrådte:
KPMG P/S, den 23.04.2025.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 23.04.2025.
Vedtægter ændret: 07.01.2025
Kapitalforhøjelsen er besluttet den 07.01.2025.
kr. 293.718,55, indbetalt kontant, kurs 5.000,00.
Kapitalen udgør herefter kr. 1.468.592,80.
Vedtægter ændret: 17.04.2024
Bestyrelse:
Fratrådte:
Michael Stanley Pedersen, den 17.04.2024, Leo Rasmussen, den 17.04.2024.
Tiltrådte:
Daniel Patterson, den 17.04.2024, Søren Ulstrup, den 17.04.2024.
Direktion:
Tiltrådte:
CFO Henrik Brian Sønderup Sørensen, den 07.03.2024.
Direktionssuppleanter:
Fratrådte:
CFO Henrik Brian Sønderup Sørensen, den 07.03.2024.
Direktion:
Fratrådte:
CFO Reto Utiger Sørensen, den 31.01.2024.
Vedtægter ændret: 01.09.2023
Kapitalforhøjelsen er besluttet den 01.09.2023.
kr. 195.812,35, indbetalt kontant, kurs 7.000,00.
Kapitalen udgør herefter kr. 1.174.874,25.
Vedtægter ændret: 08.05.2023
Vedtægter ændret: 19.04.2023
Vedtægter ændret: 19.04.2023
Vedtægter ændret: 14.12.2022
Kapitalforhøjelsen er besluttet den 14.12.2022.
kr. 28.735,65, indbetalt kontant, kurs 13.920,00.
Kapitalen udgør herefter kr. 979.061,90.
Direktion:
Fratrådte:
CFO Henrik Brian Sønderup Sørensen, den 31.10.2022.
Tiltrådte:
Reto Utiger Sørensen, den 01.11.2022.
Vedtægter ændret: 01.09.2022
Kapitalforhøjelsen er besluttet den 01.09.2022.
kr. 27.933,00, indbetalt kontant, kurs 14.320,00.
Kapitalen udgør herefter kr. 950.326,25.
Direktion:
Fratrådte:
Claus Vorreiter Jensen, (adm. dir), den 27.07.2022, Chief Innovation Officer (CINO) Morten Miller, den 27.07.2022.
Tiltrådte:
Chief Innovation Officer (CINO) Morten Miller, (adm. dir), den 27.07.2022.
Bestyrelse:
Fratrådte:
Chief Innovation Officer (CINO) Morten Miller, den 05.04.2022.
Vedtægter ændret: 05.04.2022
Direktion:
Fratrådte:
Claus Vorreiter Jensen, den 19.08.2021, Morten Miller, (adm. dir), den 19.08.2021.
Tiltrådte:
Claus Vorreiter Jensen, (adm. dir), den 12.08.2021, Morten Miller, den 12.08.2021.
Ny adresse: Blokken 75, 3460 Birkerød
Bestyrelse:
Tiltrådte:
Mette Juhl Jørgensen, den 15.04.2021, Michael Stanley Pedersen, den 15.04.2021.
Direktion:
Tiltrådte:
Claus Vorreiter Jensen, den 02.02.2021, Henrik Brian Sønderup Sørensen, den 01.03.2021.
Vedtægter ændret: 29.01.2021
Kapitalforhøjelsen er besluttet den 29.01.2021.
kr. 243.243,25, indbetalt kontant, kurs 11.100,00.
Kapitalen udgør herefter kr. 922.393,25.
Vedtægter ændret: 04.01.2021
Kapitalforhøjelsen er besluttet den 04.01.2021.
kr. 54.150,00, indbetalt kontant, kurs 1.200,00.
Kapitalen udgør herefter kr. 679.150,00.
Selskabet tegnes af en direktør sammen med et bestyrelsesmedlem eller af den samlede bestyrelse.
Direktion:
Fratrådte:
Morten Anders Ulsøe Reeslev, den 17.12.2020.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning.
Aktiver og gæld er overdraget til CVR-nummer 41951567 Mycometer A/S.
Vedtægterne er yderligere ændret
Vedtægter ændret: 17.12.2020
Vedtægter ændret: 17.12.2020
Nyt navn: BactiQuant A/S
Slettet binavn: Bactiquant A/S
Erhvervsstyrelsen har modtaget spaltningsplan for den påtænkte spaltning af CVR-nummer: 24231712 MYCOMETER A/S (indskydende fortsættende), der tillige driver virksomhed under navnene MYCOTEC A/S, Bactimatic A/S, Bactiquant A/S.
De øvrige deltagende virksomheder er en/flere nye virksomheder.
Erhvervsstyrelsen har modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 24231712 MYCOMETER A/S må antages at være tilstrækkeligt sikrede efter spaltningen.
Bestyrelse:
Fratrådte:
Morten Anders Ulsøe Reeslev, den 10.11.2020.
Tiltrådte:
Leo Rasmussen, den 10.11.2020.
Direktion:
Tiltrådte:
Morten Miller, (adm. dir), den 10.11.2020.
Vedtægter ændret: 21.10.2020
Nyt binavn: Bactiquant A/S
Revision:
Fratrådte:
PIASTER REVISORERNE, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 21.10.2020.
Tiltrådte:
CVR-NR. 25578198 KPMG P/S, Dampfærgevej 28, 2100 København Ø, den 21.10.2020.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er fusioneret med CVR-nummer: 33773544 BACTIMATIC A/S, der samtidigt er opløst.
Vedtægter ændret: 13.08.2020
Nyt binavn: Bactimatic A/S
Kapitalforhøjelse ved fusion på nominel 82.430 kr. til kurs 5.592,21. Selskabskapitalen
er herefter 625.000 kr.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 24231712 MYCOMETER A/S (fortsættende), der tillige driver virksomhed under navnene MYCOTEC A/S og CVR-nummer: 33773544 BACTIMATIC A/S (ophørende).
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 24231712 MYCOMETER A/S og CVR-nummer: 33773544 BACTIMATIC A/S må antages at være tilstrækkeligt sikrede efter fusionen.
Vedtægterne er yderligere ændret
Vedtægter ændret: 25.04.2019
Kapitalnedsættelse besluttet 25.04.2019 er gennemført 17.07.2019.
Kapitalen udgør herefter kr. 542.570,00.
Vedtægter ændret: 25.04.2019
Kapitalnedsættelse besluttet 25.04.2019 henlæggelse til særlig reserve kr. 25.000,00 til kurs 100,00.
Virksomhedens kreditorer opfordres til at indberette deres krav til virksomheden. Kreditorerne kan kræve betryggende sikkerhed for uforfaldne krav og betaling af forfaldne krav. Krav skal indberettes senest 4 uger fra dags dato.
Selskabet tegnes af en direktør eller af den samlede bestyrelse..
Bestyrelse:
Fratrådte:
Morten Miller, (formand), den 13.03.2019, Asger Ulsøe Reeslev, den 13.03.2019.
Tiltrådte:
Morten Miller, den 13.03.2019, Henrik Skaanderup, (formand), den 13.03.2019.
Bestyrelse:
Fratrådte:
Morten Miller, den 01.09.2018, Morten Anders Ulsøe Reeslev (formand), den 01.09.2018.
Tiltrådte:
Morten Miller (formand), den 01.09.2018, Morten Anders Ulsøe Reeslev, den 01.09.2018.
Direktion:
Fratrådte:
Steen Søndergaard-Larsen (adm. dir), den 31.08.2018.
Tiltrådte:
Morten Anders Ulsøe Reeslev, den 01.09.2018.
Bestyrelse:
Fratrådte:
Jan Clair Nielsen, den 03.05.2017.
Tiltrådte:
Asger Ulsøe Reeslev, den 03.05.2017.
Vedtægter ændret: 09.09.2016
Kapitalforhøjelsen er besluttet den 09.09.2016.
kr. 42.570,00, indbetalt i værdier, kurs 5.333,33.
Kapitalen udgør herefter kr. 567.570,00.
Bestyrelse:
Fratrådte:
Morten Anders Ulsøe Reeslev, den 09.09.2016.
Tiltrådte:
Morten Anders Ulsøe Reeslev (formand), den 09.09.2016.
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse..
Formål ændret: Selskabets formål er at drive virksomhed med fremstilling og salg af mikrobiologiske metoder til måling af mikrobiel kontaminering, og dermed beslægtet virksomhed.
Bestyrelse:
Fratrådte:
.
Direktion:
Fratrådte:
Morten Miller, den 31.12.2015.
Tiltrådte:
Steen Søndergaard-Larsen (adm. dir), den 01.01.2016.
Ny adresse:
Dr Neergaards Vej 3, 2970 Hørsholm.
Ny kommune:
Rudersdal.
Vedtægter ændret:
29.10.2009.
Kapitalforhøjelse:
kr. 25.000,00 indbetalt ved overførte reserver / overskud, kurs 100,00.
Kapitalen udgør herefter kr. 525.000,00.
Vedtægter ændret:
04.04.2008.
Kapitalforhøjelse:
kr. 375.000,00 indbetalt ved overførte reserver / overskud, kurs 2.053,10.
Selskabet er omdannet til et A/S med CVR-nr 24231712.
NAVN: MYCOMETER A/S.
ADRESSE: Lersø Parkalle 40, 2100 København Ø.
Kommune:
København.
Binavn:
MYCOTEC A/S (MYCOMETER A/S).
Kapital kr. 500.000,00.
Bestyrelse:
Morten Miller, den 04.04.2008, Direktør Jan Clair Nielsen, den 04.04.2008, Morten Anders Ulsøe Reeslev, den 04.04.2008.
Direktion:
Selskabet tegnes af en direkør eller af den samlede bestyrelse.
Revision:
CVR-NR. 28849540 PIASTER, LØFGREEN & PARTNERE, STATSAUTORISERET REVISIONSAKTIESELSKAB, c/o Løfgreen & Partnere, Abildgårdsparken 8A, 3460 Birkerød.
Regnskabsår:
01.01 - 31.12.
P-number 1006431176Blokken 75, 3460 Birkerød